Nature Genetics APC and Open Access: Portfolio Pricing, GWAS Data Costs, and Institutional Coverage

Nature Genetics is a hybrid journal:

1. Subscription track (default, $0): Your article is published behind the Springer Nature paywall. Readers access it through library subscriptions. No fee to the author.
2. Gold open access track ($12,850): Your article is immediately free to read under a Creative Commons license. The APC is paid by you, your funder, or your institution.

For genetics research, the subscription track has a practical advantage that's often overlooked. Most genetics researchers work at institutions with Springer Nature subscriptions, so they can already access the content. And the data underlying your paper (which is often the most valuable part) is typically deposited in public repositories like dbGaP, EGA, or GEO regardless of the article's access status.

That means even a paywalled Nature Genetics paper has its most important component (the data) freely available. The article itself provides interpretation and context, which matters, but the paywall is less of a barrier in genetics than in clinical fields where practitioners may not have institutional access.

Springer Nature's Read & Publish network covers Nature Genetics. Over 1,000 institutions in 30+ countries have active agreements:

For genetics researchers specifically, the institutional coverage map matters because large GWAS consortia often involve authors from dozens of institutions across multiple countries. The corresponding author's institution determines whether the APC is covered. If the corresponding author is at a covered UK university, the APC is zero, even if co-authors are at uncovered institutions elsewhere.

This creates a strategic consideration for multi-center genetics studies: who should be the corresponding author? If one PI is at an institution with a Springer Nature deal and another isn't, listing the covered PI as corresponding author saves $12,850.

Springer Nature applies the same waiver structure across the entire portfolio:

Automatic waivers:

• Corresponding authors from Research4Life Group A countries (low-income nations) get a full APC waiver.
• Group B countries (lower-middle-income) receive a 50% discount.

Case-by-case waivers:

• Available for financial hardship at the time of acceptance.
• Not guaranteed. Editors don't see the application.

No special genetics or consortium discounts:

• Large consortium papers (e.g., 50+ author GWAS) don't receive volume discounts. The APC is the same whether your paper has 3 authors or 300.

For researchers in Africa and South Asia doing population genetics, the automatic waiver system is particularly relevant. Several landmark studies of African genetic diversity have been published in Nature Genetics with fee support. The waiver system, while imperfect, does work for this use case.

Genetics research is disproportionately funded by agencies that mandate open access. NIH (which funds most US genetics research through NHGRI, NIMH, and other institutes), Wellcome Trust (a major funder of genomics in the UK), and ERC all require public access.

The NIH's Genomic Data Sharing policy adds another layer: not only must the paper be accessible, but the underlying genomic data must be deposited in an approved repository with appropriate access controls. This is separate from the OA decision and applies regardless of whether you choose gold OA or the subscription track.

For Plan S compliance, select CC BY at the licensing stage. CC BY-NC won't satisfy cOAlition S funders. This is a common mistake.

Beyond the APC, genetics papers in Nature Genetics carry costs that other fields don't face:

• Data deposition fees: Large genomic datasets deposited in the European Genome-phenome Archive (EGA) or dbGaP are free, but preparing data for compliant deposition (anonymization, formatting, access controls) requires staff time. For a large GWAS, this can take weeks.
• Compute costs for reproducibility: Nature Genetics increasingly requires reproducible analysis pipelines. Hosting these on cloud platforms (AWS, Google Cloud) for reviewer verification can cost hundreds to thousands of dollars.
• Consortium coordination: Multi-center genetics papers require data sharing agreements, ethics approvals across institutions, and coordination that costs time and administrative effort.
• Tax on the APC: VAT applies in the EU and can add 15-25% on top of $12,850.
• Supplementary files: Genetics papers often have enormous supplementary tables (hundreds of association results, variant annotations). Springer Nature hosts these at no extra charge, but formatting them takes significant effort.

For Nature Genetics specifically:

1. Institution has a Springer Nature Read & Publish deal? Choose OA. The APC is covered. This is the most common path for authors at European universities.
2. Large consortium paper? Make sure the corresponding author is at a covered institution. This single decision can save $12,850.
3. NIH-funded, no institutional deal? Publish via subscription for free. Deposit in PMC after 6 months. The genomic data is public regardless.
4. Considering alternatives? Genome Biology ($4,290, gold OA, same publisher) is worth a serious look for computational and genomics-focused work.

The real barrier at Nature Genetics isn't the APC. It's the editorial expectation. The journal wants genetics discoveries with clear biological mechanisms, not just statistical associations. A GWAS finding 50 new loci is interesting, but Nature Genetics wants to see functional follow-up on at least some of them. Check our Nature Genetics impact factor breakdown for more on what the editors look for.

Before submitting, make sure your manuscript meets the structural and analytical standards. Run a free readiness scan to catch formatting and framing issues that trigger desk rejection at this level.

For current APC amounts and submission guidelines, visit the Nature Genetics author information page.